March 24th 2021
Ophthalmologists share the most pressing issues on their mind within the glaucoma space — and why losing sleep from time to time may actually be a good thing.
January 28th 2021
Rishi P. Singh, MD, highlights various treatment options available for the management of patients with age-related macular degeneration, as well as the status of potential therapies.
January 14th 2021
Shaily Shah, MD, and Esen Karamursel Akpek, MD, discuss managing the potential ocular toxicities that can occur with belantamab mafodotin-blmf in patients with relapsed/refractory multiple myeloma, as well as the collaborative role between ophthalmologists and oncologists.
January 13th 2021
From patient care and treating glaucoma to the ongoing pandemic, ophthalmologists share the most pressing thoughts of concern leaving them awake at night.
Re-Vana Therapeutics raises $11.9 million in Series A financing for development of ophthalmic therapeutics
Harrow and iOR Partners expand national product supply agreement
OWL, WIO to co-host networking reception during Hawaiian Eye
